 <h1>Pancrease MT 10 Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>pancrelipase</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about pancrelipase. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Pancrease MT 10.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to pancrelipase: oral capsule, oral capsule delayed release, oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, pancrelipase (the active ingredient contained in Pancrease MT 10) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking pancrelipase:</p><p>
<i>Rare</i>
</p><ul>
<li>Skin rash or hives</li>
</ul><p>
<i>With high doses</i>
</p><ul>
<li>Bowel blockage</li>
<li>diarrhea</li>
<li>nausea</li>
<li>stomach cramps or pain</li>
</ul><p>
<i>With very high doses</i>
</p><ul>
<li>Blood in the urine</li>
<li>joint pain</li>
<li>swelling of the feet or lower legs</li>
</ul><p>
<i>With powder dosage form or powder from opened capsules</i>
</p><ul>
<li>Stuffy nose</li>
<li>tightness in the chest</li>
<li>trouble breathing</li>
</ul><p>
<i>With tablets</i>
</p><ul>
<li> Irritation of the mouth</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Cough</li>
<li>difficulty with swallowing</li>
<li>dizziness</li>
<li>fast heartbeat</li>
<li>itching</li>
<li>noisy breathing</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>redness of the skin</li>
<li>severe stomach pain</li>
<li>unusual tiredness or weakness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of pancrelipase may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Blurred vision</li>
<li>dry mouth</li>
<li>flushed, dry skin</li>
<li>fruit-like breath odor</li>
<li>headache</li>
<li>increased hunger</li>
<li>increased thirst</li>
<li>increased urination</li>
<li>sweating</li>
<li>unexplained weight loss</li>
<li>vomiting</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Abnormal feces</li>
<li>anxiety</li>
<li>bloated feeling</li>
<li>chills</li>
<li>cold sweats</li>
<li>confusion</li>
<li>cool, pale skin</li>
<li>depression</li>
<li>excess air or gas in the stomach or intestines</li>
<li>feeling of fullness</li>
<li>fever</li>
<li>frequent bowel movements</li>
<li>loss of consciousness</li>
<li>muscle aches</li>
<li>nightmares</li>
<li>passing gas</li>
<li>runny nose</li>
<li>seizures</li>
<li>shakiness</li>
<li>slurred speech</li>
<li>sore throat</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Difficulty having a bowel movement</li>
<li>difficulty with moving</li>
<li>muscle aching or cramping</li>
<li>muscle pains or stiffness</li>
<li>muscle spasm</li>
<li>swollen joints</li>
</ul><p>
<!-- end oral capsule, oral capsule delayed release, oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to pancrelipase: oral capsule, oral capsule extended release, oral delayed release capsule, oral powder for reconstitution, oral tablet, oral tablet extended release</i></p><h3>General</h3><p>The most commonly reported side effects included gastrointestinal complaints, abdominal pain, and headaches.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Bowel stricture formation occasionally occurred in children with cystic fibrosis who received high doses.</p>
<p></p>
<p>Moderate duodenitis and gastritis occurred in a patient with exocrine pancreatic insufficiency due to cystic fibrosis 16 days after completing treatment with 4000 lipase units/gram fat ingested per day for 5 to 6 days, followed by placebo for an additional 5 to 6 days.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Gastrointestinal complaints (up to 55%), abdominal pain (up to 18%), vomiting (up to 12%)</p>
<p><b>Common</b> (1% to 10%): Abdominal discomfort, abdominal distention, abdominal pain upper, abdominal tenderness, abnormal feces, anal pruritus, ascites, constipation, diarrhea, dyspepsia, early satiety, flatulence, frequent bowel movements, nausea</p>
<p><b>Uncommon</b> (0.1% to 1%): Bowel stricture formation</p>
<p><b>Frequency not reported</b>: Duodenitis, fibrosing colonopathy, gastritis, steatorrhea, strictures of the ileocecum</p>
<p><b>Postmarketing reports</b>: Distal intestinal obstruction syndrome (DIOS)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 15%)</p>
<p><b>Common</b> (1% to 10%): Dizziness</p>
<p><b>Postmarketing reports</b>: Dull headache<sup>[Ref]</sup></p><p>A dull headache was reported by a patient receiving treatment with ursodeoxycholic acid concomitantly.  The event resolved without sequelae after discontinuation of this drug.<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Blood cholesterol decreased, blood glucose increased, decreased appetite, diabetes mellitus, diabetes mellitus including subtypes, hyperglycemia, hypoglycemia, weight decreased</p>
<p><b>Frequency not reported</b>: Hyperuricemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): ALT increased, AST increased, biliary tract stones, blood alkaline phosphatase increased, cholangitis, GGT increased, hydrocholecystis</p>
<p><b>Postmarketing reports</b>: Asymptomatic liver enzyme elevations<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia, hematocrit, hemoglobin, red blood cell count, increased white blood cell count</p>
<p><b>Frequency not reported</b>: Transient neutropenia with/without clinical sequelae<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Bronchitis, cough, nasopharyngitis, oropharyngeal pain, respiratory tract infection</p>
<p><b>Postmarketing reports</b>: Asthma<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia, malaise, pain, pyrexia</p>
<p><b>Frequency not reported</b>: Fatigue<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus, rash, skin reactions</p>
<p><b>Frequency not reported</b>: Itching, urticaria/hives</p>
<p><b>Postmarketing reports</b>: Blotchy/red facial rash<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia, back pain, musculoskeletal pain</p>
<p><b>Postmarketing reports</b>: Muscle spasm, myalgia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Contusion, hypertension, peripheral edema<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): Metastases to specific sites, recurrent pancreatic carcinoma</p>
<p><b>Postmarketing reports</b>: Recurrence of preexisting carcinoma<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, irritability<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Renal cyst<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Viral infection<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>A patient with a known history of allergy to another pancrelipase (the active ingredient contained in Pancrease MT 10) product developed a mild allergic reaction, including red, blotchy facial rash and itching.  The event resolved without sequelae after discontinuation of this drug.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Anaphylactic reactions, hypersensitivity</p>
<p><b>Postmarketing reports</b>: Anaphylaxis, mild allergic reactions, severe allergic reactions<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Hyperuricosuria<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Postmarketing reports</b>: Blurred vision<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Ultrase (pancrelipase)." Scandipharm Inc, Birmingham, AL. </p><p id="ref_2">2. "Product Information. Cotazym-S (pancrelipase)." Organon, West Orange, NJ. </p><p id="ref_3">3. "Product Information. Creon 10 (pancrelipase)." Solvay Pharmaceuticals Inc, Marietta, GA. </p><p id="ref_4">4. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_5">5. "Product Information. Zymase (pancrelipase)." Organon, West Orange, NJ. </p><p id="ref_6">6. "Product Information. Pancrease (pancrelipase)." McNeil Pharmaceutical, Raritan, NJ. </p><p id="ref_7">7. "Product Information. Cotazym (pancrelipase)." Organon, West Orange, NJ. </p><p id="ref_8">8. "Product Information. Viokase (pancrelipase)." Wyeth-Ayerst Laboratories, Philadelphia, PA. </p><p id="ref_9">9. "Product Information. Pancrease MT (pancrelipase)." McNeil Pharmaceutical, Raritan, NJ. </p><p id="ref_10">10. "Product Information. Creon 5 (pancrelipase)." Solvay Pharmaceuticals Inc, Marietta, GA. </p><p id="ref_11">11. "Product Information. Ku-zyme (pancrelipase)." Schwarz Pharma, Mequon, WI. </p><p id="ref_12">12. "Product Information. Creon 20 (pancrelipase)." Solvay Pharmaceuticals Inc, Marietta, GA. </p><p id="ref_13">13. "Product Information. Ultrase MT (pancrelipase)." Scandipharm Inc, Birmingham, AL. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Pancrease MT 10 (pancrelipase)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Drug class: digestive enzymes</li>
</ul>
<h3>Consumer resources</h3>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Creon, Zenpep, Pancreaze, Pertzye, ... +5 more</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Chronic Pancreatitis</li>
<li>Cystic Fibrosis</li>
<li>Pancreatic Exocrine Dysfunction</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to pancrelipase: oral capsule, oral capsule extended release, oral delayed release capsule, oral powder for reconstitution, oral tablet, oral tablet extended release</i></p><h3>General</h3><p>The most commonly reported side effects included gastrointestinal complaints, abdominal pain, and headaches.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Bowel stricture formation occasionally occurred in children with cystic fibrosis who received high doses.</p><p></p><p>Moderate duodenitis and gastritis occurred in a patient with exocrine pancreatic insufficiency due to cystic fibrosis 16 days after completing treatment with 4000 lipase units/gram fat ingested per day for 5 to 6 days, followed by placebo for an additional 5 to 6 days.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Gastrointestinal complaints (up to 55%), abdominal pain (up to 18%), vomiting (up to 12%)</p><p><b>Common</b> (1% to 10%): Abdominal discomfort, abdominal distention, abdominal pain upper, abdominal tenderness, abnormal feces, anal pruritus, ascites, constipation, diarrhea, dyspepsia, early satiety, flatulence, frequent bowel movements, nausea</p><p><b>Uncommon</b> (0.1% to 1%): Bowel stricture formation</p><p><b>Frequency not reported</b>: Duodenitis, fibrosing colonopathy, gastritis, steatorrhea, strictures of the ileocecum</p><p><b>Postmarketing reports</b>: Distal intestinal obstruction syndrome (DIOS)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 15%)</p><p><b>Common</b> (1% to 10%): Dizziness</p><p><b>Postmarketing reports</b>: Dull headache<sup>[Ref]</sup></p><p>A dull headache was reported by a patient receiving treatment with ursodeoxycholic acid concomitantly.  The event resolved without sequelae after discontinuation of this drug.<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Blood cholesterol decreased, blood glucose increased, decreased appetite, diabetes mellitus, diabetes mellitus including subtypes, hyperglycemia, hypoglycemia, weight decreased</p><p><b>Frequency not reported</b>: Hyperuricemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): ALT increased, AST increased, biliary tract stones, blood alkaline phosphatase increased, cholangitis, GGT increased, hydrocholecystis</p><p><b>Postmarketing reports</b>: Asymptomatic liver enzyme elevations<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia, hematocrit, hemoglobin, red blood cell count, increased white blood cell count</p><p><b>Frequency not reported</b>: Transient neutropenia with/without clinical sequelae<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Bronchitis, cough, nasopharyngitis, oropharyngeal pain, respiratory tract infection</p><p><b>Postmarketing reports</b>: Asthma<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia, malaise, pain, pyrexia</p><p><b>Frequency not reported</b>: Fatigue<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus, rash, skin reactions</p><p><b>Frequency not reported</b>: Itching, urticaria/hives</p><p><b>Postmarketing reports</b>: Blotchy/red facial rash<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia, back pain, musculoskeletal pain</p><p><b>Postmarketing reports</b>: Muscle spasm, myalgia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Contusion, hypertension, peripheral edema<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): Metastases to specific sites, recurrent pancreatic carcinoma</p><p><b>Postmarketing reports</b>: Recurrence of preexisting carcinoma<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, irritability<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Renal cyst<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Viral infection<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>A patient with a known history of allergy to another pancrelipase (the active ingredient contained in Pancrease MT 10) product developed a mild allergic reaction, including red, blotchy facial rash and itching.  The event resolved without sequelae after discontinuation of this drug.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Anaphylactic reactions, hypersensitivity</p><p><b>Postmarketing reports</b>: Anaphylaxis, mild allergic reactions, severe allergic reactions<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Hyperuricosuria<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Postmarketing reports</b>: Blurred vision<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Ultrase (pancrelipase)." Scandipharm Inc, Birmingham, AL. </p><p id="ref_2">2. "Product Information. Cotazym-S (pancrelipase)." Organon, West Orange, NJ. </p><p id="ref_3">3. "Product Information. Creon 10 (pancrelipase)." Solvay Pharmaceuticals Inc, Marietta, GA. </p><p id="ref_4">4. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_5">5. "Product Information. Zymase (pancrelipase)." Organon, West Orange, NJ. </p><p id="ref_6">6. "Product Information. Pancrease (pancrelipase)." McNeil Pharmaceutical, Raritan, NJ. </p><p id="ref_7">7. "Product Information. Cotazym (pancrelipase)." Organon, West Orange, NJ. </p><p id="ref_8">8. "Product Information. Viokase (pancrelipase)." Wyeth-Ayerst Laboratories, Philadelphia, PA. </p><p id="ref_9">9. "Product Information. Pancrease MT (pancrelipase)." McNeil Pharmaceutical, Raritan, NJ. </p><p id="ref_10">10. "Product Information. Creon 5 (pancrelipase)." Solvay Pharmaceuticals Inc, Marietta, GA. </p><p id="ref_11">11. "Product Information. Ku-zyme (pancrelipase)." Schwarz Pharma, Mequon, WI. </p><p id="ref_12">12. "Product Information. Creon 20 (pancrelipase)." Solvay Pharmaceuticals Inc, Marietta, GA. </p><p id="ref_13">13. "Product Information. Ultrase MT (pancrelipase)." Scandipharm Inc, Birmingham, AL. </p><h2>More about Pancrease MT 10 (pancrelipase)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Drug class: digestive enzymes</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Chronic Pancreatitis</li>
<li>Cystic Fibrosis</li>
<li>Pancreatic Exocrine Dysfunction</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>